Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.

Sallard, E; Belhadi, D; Lescure, F-X; Yazdanpanah, Y; Peiffer-Smadja, N

Sallard, E; Belhadi, D; Lescure, F-X; Yazdanpanah, Y; Peiffer-Smadja, N.

Afiliação

Sallard E; École normale supérieure de Paris, 45, rue D'Ulm, 75005 Paris, France; Department of Human Medicine, Faculty of Health, Witten-Herdecke University, 58453 Witten, Germany. Electronic address: erwan.sallard@ens.psl.eu.
Belhadi D; Université de Paris, INSERM, IAME, 75006 Paris, France.
Lescure FX; Université de Paris, INSERM, IAME, 75006 Paris, France; Bichat-Claude Bernard University Hospital, AP-HP, 75018 Paris, France.
Yazdanpanah Y; Université de Paris, INSERM, IAME, 75006 Paris, France; Bichat-Claude Bernard University Hospital, AP-HP, 75018 Paris, France.
Peiffer-Smadja N; Université de Paris, INSERM, IAME, 75006 Paris, France; Bichat-Claude Bernard University Hospital, AP-HP, 75018 Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.

Infect Dis Now ; 51(1): 7-13, 2021 02.

Article em En | MEDLINE | ID: mdl-33022293

Assuntos

COVID-19/prevenção & controle; Ensaios Clínicos como Assunto; Profilaxia Pós-Exposição; Profilaxia Pré-Exposição; Protocolos Clínicos; Humanos; SARS-CoV-2

Palavras-chave

COVID-19; Prophylaxis; Repurposed chemotherapy; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Profilaxia Pós-Exposição / Profilaxia Pré-Exposição / COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Infect Dis Now Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google